ASCO was honored with the Dorothy Schachne Partners in Progress Award by CancerCare

The American Society of Clinical Oncology (ASCO) was honored with the Dorothy Schachne Partners in Progress Award at CancerCare’s 2025 National Gala, held on April 22 at the Ziegfeld Ballroom in New York City. This prestigious award recognizes ASCO’s unwavering commitment to advancing patient-centered cancer care through research, education, and advocacy.​

Dr. Clifford Hudis, ASCO’s Chief Executive Officer and Executive Vice Chair of Conquer Cancer, the ASCO Foundation, accepted the award on behalf of the organization. The award was presented by Dr. Jay Schachne, son of the late Dorothy Schachne, in whose memory the award is named. 

The 2025 CancerCare Gala also recognized Bluprint Oncology—Powered by Petauri and Petauri with the Dorothy Schachne Corporate Achievement Award for their contributions to cancer care.

About the Award

The Dorothy Schachne Partners in Progress Award is named in memory of Dorothy Schachne, a passionate advocate for people living with cancer and a key supporter of initiatives focused on patient-centered services.
This award recognizes organizations and individuals who have made outstanding contributions to improving the lives of cancer patients, particularly through partnerships that advance care, support, and innovation.

Why This Recognition Matters

ASCO’s partnership with CancerCare underscores a shared commitment to improving patient outcomes, especially in vulnerable and underserved populations.

In their announcement, ASCO said:

“We are incredibly honored! This week, we received the Dorothy Schachne Partners in Progress Award from our valued partners at CancerCare. With our shared focus on patients, we are especially grateful for the essential role CancerCare plays in our collaborative work to improve the lives of people with cancer.”

By combining ASCO’s global leadership in cancer research and practice with CancerCare’s historic role in providing direct support services, the two organizations have enhanced access, education, and holistic care for countless individuals and families affected by cancer.

Michael Parisi, Chief Client Officer at Lumanity, also shared the news as following: 

“It was an honor to present ASCO with the Dorothy Schachne Partners in Progess award at tonight’s CancerCare Gala. This award recognizes ASCO commitment and dedication to the highest quality scientific research, ongoing commitment to education and patient advocacy.

Accepting the award are ASCO’s Chief Medical Officer Dr Julie Gralow and CEO Dr Cliff Hudis, presented by Dorothy’s son, Dr Jay Schachne who was there to honor his mother. We would like to express our deepest gratitude for your outstanding contributions, partnerships and unwavering dedication to improving cancer care globally!”

This recognition highlights not only past achievements but also inspires continued collaboration toward a future where every patient receives equitable, compassionate, and cutting-edge care.

A Legacy of Partnership

Over the years, ASCO and CancerCare have:

• Co-developed educational initiatives for patients and caregivers.
• Advocated for policies that prioritize patient-centered care.
• Facilitated access to resources and psychosocial support for people navigating cancer diagnoses and treatments.
• Elevated patient voices in shaping research and care models.

This award is a celebration of those shared efforts and a powerful reminder of how partnerships fuel progress in oncology.

Congratulations to ASCO and CancerCare!

At OncoDaily, we applaud this remarkable achievement and look forward to seeing even greater impact from this partnership in the future.

Learn more at Cancercare.org.

Stay tuned for more updates on oncology leadership, partnerships, and patient-centered innovations — only on OncoDaily!